American News Group News Commentary - The race to bring artificial intelligence into drug discovery has become one of the most closely watched stories in both biotech and technology. Pharmaceutical companies are pouring money into AI, chipmakers are courting the life-sciences market, and a wave of specialized companies is trying to prove that machine reasoning can actually speed the search for new medicines. This week, one of the smaller names in that race stepped onto a very large stage.